IL13 and breast cancer: As shown in Table 2, median levels of ANG, ANGST, 8-iso-PGF2α, SNCG, and IL-13 were 9.3-fold, 6.6-fold, 1.5-fold, 1.3-fold, and 1.8-fold higher, respectively, in the BC patients compared with the control group.